Lisata Therapeutics Inc
NASDAQ:LSTA

Watchlist Manager
Lisata Therapeutics Inc Logo
Lisata Therapeutics Inc
NASDAQ:LSTA
Watchlist
Price: 2.06 USD -2.37% Market Closed
Market Cap: 18.2m USD

Operating Margin
Lisata Therapeutics Inc

-1 876.5%
Current
-634%
Average
-4.3%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-1 876.5%
=
Operating Profit
-20.1m
/
Revenue
1.1m

Operating Margin Across Competitors

No Stocks Found

Lisata Therapeutics Inc
Glance View

Market Cap
18m USD
Industry
Biotechnology

Lisata Therapeutics Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Basking Ridge, New Jersey and currently employs 27 full-time employees. Lisata Therapeutics, Inc., formerly Caladrius Biosciences, Inc., is a clinical-stage biopharmaceutical company. The firm is engaged in the discovery, development, and commercialization of therapies for the treatment of advanced solid tumors and other major diseases. The firm focuses primarily on advancing its CendR Platform technology product candidates in a range of oncology indications. Its lead investigational product candidate, LSTA1, is designed to modify the tumor microenvironment by activating an uptake pathway that allows anti-cancer drugs to penetrate solid tumors. LSTA1 actuates an active transport system in a tumor-specific manner, resulting in systemically co-administered anti-cancer drugs penetrating and accumulating in the tumor, while normal tissues are not affected. In addition, the Company also has clinical development programs based on its autologous CD34+ cell therapy technology platform.

LSTA Intrinsic Value
HIDDEN
Show
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-1 876.5%
=
Operating Profit
-20.1m
/
Revenue
1.1m
What is the Operating Margin of Lisata Therapeutics Inc?

Based on Lisata Therapeutics Inc's most recent financial statements, the company has Operating Margin of -1 876.5%.

Back to Top